Stay updated with breaking news from Biological E. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Read more about Biological E to start phase 3 clinical trials of its Covid-19 vaccine soon on Business Standard. The phase III clinical study, to be conducted in 15 sites across India, will evaluate the immunogenicity and safety of Biological E's vaccine candidate in 1,268 healthy subjects
April 24, 2021 The Phase III clinical study to be conducted in 15 sites across India Biological E. Ltd, has successfully completed the Phase I and II clinical trial of its Covid-19 subunit vaccine candidate in India and received the approval to start the Phase III clinical trial from the Central Drugs Standard Control Organization (CDSCO) - Subject Expert Committee (SEC). Its candidate includes an antigen developed by Texas Children’s Hospital Center for Vaccine Development and in-licensed from BCM Ventures, Baylor College of Medicine’s integrated commercialization team, along with Dyna...
Biological E to initiate Ph III trial of COVID-19 vaccine candidate Biological E to initiate Ph III trial of COVID-19 vaccine candidate 24 April 2021 | News Image credit- shutterstock.com Biological E. Limited (BE), a Hyderabad-based vaccine and pharmaceutical company, has announced that it has successfully completed the Phase I/II clinical trial of its COVID-19 subunit vaccine candidate in India and received the approval to start the Phase III clinical trial from the Central Drugs Standard Control Organization (CDSCO) - Subject Expert Committee (SEC). BE started the Phase I/II Clinical Tri...
J&J's Single-Dose Covid-19 Vaccine Likely To Be Imported To India By June-July: DBT Secretary Renu Swarup (A picture of vaccine vials from Johnson and Johnson) United States (US) based pharmaceutical major Johnson & Johnson (J&J) is working closely with Hyderabad based vaccine maker Biological E to facilitate the technology transfer for domestic manufacturing of its single-dose COVID-19 vaccine in India while it is expected that the vaccine's import into the country will begin by June-July, reports Livemint. Sharing the development, secretary of the department of biotechnology Renu Swarup sa...
Department of Biotechnology Secretary Renu Swarup. File Renu Swarup said a financial support of ₹400 crore is being provided to vaccine candidates from Zydus Cadilla, Biological E, Gennova and Bharat Biotech Efforts are being ramped up for massive production of vaccines and make them available in the shortest possible time, a top government official said on Wednesday, stressing that India currently has a promising pipeline of four-five COVID-19 vaccine candidates, while three have already been approved for emergency use. Department of Biotechnology Secretary Renu Swarup said a financi...